# Two-Stage Microwave Hyperthermia Using Magnetic Nanoparticles for Optimal Chemotherapy Activation in Liver Cancer: Concept and Preliminary Tests on Wistar Rat Model

## TL;DR

This study explores a two-stage microwave hyperthermia method using magnetic nanoparticles to enhance chemotherapy in liver cancer, showing potential for future patient treatments.

## Contribution

The novel approach combines two microwave stages with magnetic nanoparticles to optimize chemotherapy delivery in liver cancer.

## Key findings

- 42 °C was found to be the optimal temperature for liver tissue, causing minimal inflammation while inducing cellular changes.
- The two-stage method improved nanoparticle accumulation and localized chemotherapy drug release in the tumor.
- Hyperthermic effects were not fully uniform, suggesting the need for improved control in future studies.

## Abstract

Liver cancer has a poor prognosis and limited effective treatments. This study explores a modern therapeutic strategy combining two-stage microwave hyperthermia with magnetic nanoparticles, tested in an adult male Wistar rat liver model. The approach involves an initial microwave heating of the tumor area to increase blood flow and tissue permeability, improving the accumulation of nanoparticles. After nanoparticle administration, a second microwave treatment produces localized heating that directly damages tumor tissue and promotes the local release of chemotherapy drugs carried by the nanoparticles. Our results indicate that 42 °C is the most suitable temperature for liver tissue, inducing localized cellular alterations without causing significant inflammation. Although the hyperthermic effects were not fully uniform, these findings support the potential of this combined chemo-thermal approach. Overall, the described technique represents a promising strategy that warrants further investigation for future application in patients with liver cancer.

Background/Objectives: Liver cancer is among the most frequent poor-prognosis malignancies worldwide, with currently insufficient effective treatment. The two-stage microwave hyperthermia using magnetic nanoparticles is a modern technique designed to specifically target tumor tissues and facilitate chemotherapy activation, with promising results from fundamental studies across various tumor types. The method consists of a first irradiation, performed before nano-assemblies administration. This is intended to sensitize the tumor by inducing a hyperthermic effect, leading to increasing blood supply, enhancing endothelial damage/permeation and inflammatory activation, with the final goal of improving the diffusion/retention of nano-assemblies in the tumor. Subsequently, the second microwave irradiation follows the injection in the hepatic artery and diffusion in the tumor of the activated nano-assemblies, to further determine a strong, but localized and focalized hyperthermic action. Nano-magnetic assemblies for hyperthermia accomplish the proposed chemo-thermal delivery, i.e., act per se on the tumor and also destabilize co-administered assemblies of nanoparticles loaded with chemotherapeutics, which would be consequently released locally in the most efficient way. This article aims to demonstrate the efficacy of this therapeutic approach in a rat liver model and its potential applicability in patients with liver tumors. Methods: Adult male Wistar rats were used to obtain liver samples, which were divided into three groups, each receiving a different hyperthermia protocol in terms of temperature (41–45 °C), duration, and co-administration of nanoparticles. Results: The most suitable exposure temperature for rat liver appears to be 42 °C, resulting in vacuolar degeneration lesions at the focal level. The effects of thermal conditioning do not appear to be homogeneous in the tested liver, and the controlling environment and methodology should be improved in the near future. The level of hepatic inflammation, as indicated by elevated interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-α) levels, appears negligible under the current hyperthermia protocol. Conclusions: Two-stage microwave hyperthermia using magnetic nanoparticles is a promising therapeutic modality for liver cancer, with promising results from animal studies opening the way for further research in humans.